Aggregated
58% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Rodman & Renshaw
At Rodman & Renshaw, this analyst has issued 21 tracked ratings across 21 distinct tickers, primarily focusing on the captured sample with a 58.3% success rate in the sources covered.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ACHV | 2024-11-14 | buy | $12.00 | Aggregated |
| ACHVACHIEVE LIFE SCIENCES INC. | 2024-11-14 | unknown | $12.00 | Aggregated |
| ADIL | 2024-11-14 | buy | $8.00 | Aggregated |
| ADILADIAL PHARMACEUTICALS INC | 2024-11-14 | unknown | $8.00 | Aggregated |
| EPRX | 2024-11-14 | buy | $9.00 | Aggregated |
| EPRXEUPRAXIA PHARMACEUTICALS INC | 2024-11-14 | unknown | $9.00 | Aggregated |
| OMEROMEROS CORPORATION | 2024-11-14 | unknown | $9.00 | Aggregated |
| RMTI | 2024-11-14 | buy | $5.00 | Aggregated |
| RMTIROCKWELL MEDICAL INC | 2024-11-14 | unknown | $5.00 | Aggregated |
| EBS | 2024-09-13 | buy | $16.00 | Aggregated |
| EBSEMERGENT BIOSOLUTIONS INC | 2024-09-13 | unknown | $16.00 | Aggregated |
| CRMDCORMEDIX INC | 2024-08-26 | unknown | $13.00 | Aggregated |
| MIST | 2024-08-22 | buy | $9.00 | Aggregated |
| HRTX | 2024-06-13 | buy | $7.00 | Aggregated |
| HRTXHERON THERAPEUTICS INC | 2024-06-13 | unknown | $7.00 | Aggregated |
| MNKDMANNKIND CORP | 2024-06-13 | unknown | $8.00 | Aggregated |
| RANI | 2024-06-13 | buy | $10.00 | Aggregated |
| RANIRANI THERAPEUTICS HOLDINGS INC - ORDINARY SHARES CLASS A | 2024-06-13 | unknown | $10.00 | Aggregated |
| SCLX | 2024-06-13 | buy | $13.00 | Aggregated |
| SCLXSCILEX HOLDING COMPANY | 2024-06-13 | unknown | $13.00 | Aggregated |
| TRVITREVI THERAPEUTICS INC | 2024-06-13 | unknown | $7.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| ACHV | 1 | 2024-11-14 | Aggregated |
| ACHVACHIEVE LIFE SCIENCES INC. | 1 | 2024-11-14 | Aggregated |
| ADIL | 1 | 2024-11-14 | Aggregated |
| ADILADIAL PHARMACEUTICALS INC | 1 | 2024-11-14 | Aggregated |
| EPRX | 1 | 2024-11-14 | Aggregated |
| EPRXEUPRAXIA PHARMACEUTICALS INC | 1 | 2024-11-14 | Aggregated |
| OMEROMEROS CORPORATION | 1 | 2024-11-14 | Aggregated |
| RMTI | 1 | 2024-11-14 | Aggregated |
| RMTIROCKWELL MEDICAL INC | 1 | 2024-11-14 | Aggregated |
| EBS | 1 | 2024-09-13 | Aggregated |
| EBSEMERGENT BIOSOLUTIONS INC | 1 | 2024-09-13 | Aggregated |
| CRMDCORMEDIX INC | 1 | 2024-08-26 | Aggregated |
| MIST | 1 | 2024-08-22 | Aggregated |
| HRTX | 1 | 2024-06-13 | Aggregated |
| HRTXHERON THERAPEUTICS INC | 1 | 2024-06-13 | Aggregated |
| MNKDMANNKIND CORP | 1 | 2024-06-13 | Aggregated |
| RANI | 1 | 2024-06-13 | Aggregated |
| RANIRANI THERAPEUTICS HOLDINGS INC - ORDINARY SHARES CLASS A | 1 | 2024-06-13 | Aggregated |
| SCLX | 1 | 2024-06-13 | Aggregated |
| SCLXSCILEX HOLDING COMPANY | 1 | 2024-06-13 | Aggregated |
| TRVITREVI THERAPEUTICS INC | 1 | 2024-06-13 | Aggregated |